vs

Side-by-side financial comparison of MEDIFAST INC (MED) and Porch Group, Inc. (PRCH). Click either name above to swap in a different company.

Porch Group, Inc. is the larger business by last-quarter revenue ($121.1M vs $75.1M, roughly 1.6× MEDIFAST INC). On growth, Porch Group, Inc. posted the faster year-over-year revenue change (100.0% vs -36.9%). Over the past eight quarters, Porch Group, Inc.'s revenue compounded faster (26.4% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Porch is a website that tries to connect homeowners with local home improvement contractors. The site features advice articles, cost guide, and online booking for over 160 home projects.

MED vs PRCH — Head-to-Head

Bigger by revenue
PRCH
PRCH
1.6× larger
PRCH
$121.1M
$75.1M
MED
Growing faster (revenue YoY)
PRCH
PRCH
+136.9% gap
PRCH
100.0%
-36.9%
MED
Faster 2-yr revenue CAGR
PRCH
PRCH
Annualised
PRCH
26.4%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MED
MED
PRCH
PRCH
Revenue
$75.1M
$121.1M
Net Profit
$-4.7M
Gross Margin
69.4%
52.7%
Operating Margin
-10.4%
34.7%
Net Margin
-3.9%
Revenue YoY
-36.9%
100.0%
Net Profit YoY
2.0%
EPS (diluted)
$-1.64
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
PRCH
PRCH
Q1 26
$121.1M
Q4 25
$75.1M
$112.3M
Q3 25
$89.4M
$115.1M
Q2 25
$105.6M
$107.0M
Q1 25
$115.7M
$84.5M
Q4 24
$119.0M
$75.3M
Q3 24
$140.2M
$77.7M
Q2 24
$168.6M
$75.9M
Net Profit
MED
MED
PRCH
PRCH
Q1 26
$-4.7M
Q4 25
$-3.5M
Q3 25
$-2.3M
$-10.9M
Q2 25
$2.5M
$2.6M
Q1 25
$-772.0K
$8.4M
Q4 24
$30.5M
Q3 24
$1.1M
$14.4M
Q2 24
$-8.2M
$-64.3M
Gross Margin
MED
MED
PRCH
PRCH
Q1 26
52.7%
Q4 25
69.4%
99.5%
Q3 25
69.5%
75.6%
Q2 25
72.6%
70.9%
Q1 25
72.8%
77.4%
Q4 24
74.1%
Q3 24
75.4%
79.4%
Q2 24
73.2%
22.1%
Operating Margin
MED
MED
PRCH
PRCH
Q1 26
34.7%
Q4 25
-10.4%
14.7%
Q3 25
-4.6%
14.2%
Q2 25
-1.0%
4.7%
Q1 25
-1.1%
-1.5%
Q4 24
0.6%
33.3%
Q3 24
1.5%
-3.2%
Q2 24
-4.7%
-69.2%
Net Margin
MED
MED
PRCH
PRCH
Q1 26
-3.9%
Q4 25
-3.1%
Q3 25
-2.5%
-9.4%
Q2 25
2.3%
2.4%
Q1 25
-0.7%
9.9%
Q4 24
40.5%
Q3 24
0.8%
18.5%
Q2 24
-4.8%
-84.8%
EPS (diluted)
MED
MED
PRCH
PRCH
Q1 26
$-0.04
Q4 25
$-1.64
$0.00
Q3 25
$-0.21
$-0.10
Q2 25
$0.22
$0.00
Q1 25
$-0.07
$0.07
Q4 24
$0.08
$0.34
Q3 24
$0.10
$0.12
Q2 24
$-0.75
$-0.65

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
PRCH
PRCH
Cash + ST InvestmentsLiquidity on hand
$167.3M
$68.4M
Total DebtLower is stronger
$391.3M
Stockholders' EquityBook value
$198.9M
$26.3M
Total Assets
$248.0M
$806.6M
Debt / EquityLower = less leverage
14.87×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
PRCH
PRCH
Q1 26
$68.4M
Q4 25
$167.3M
$57.3M
Q3 25
$173.5M
$85.0M
Q2 25
$162.7M
$79.8M
Q1 25
$164.6M
$70.4M
Q4 24
$162.3M
$191.7M
Q3 24
$170.0M
$238.6M
Q2 24
$163.5M
$308.4M
Total Debt
MED
MED
PRCH
PRCH
Q1 26
$391.3M
Q4 25
$392.8M
Q3 25
$387.1M
Q2 25
$394.1M
Q1 25
$409.2M
Q4 24
$403.9M
Q3 24
$399.0M
Q2 24
$436.8M
Stockholders' Equity
MED
MED
PRCH
PRCH
Q1 26
$26.3M
Q4 25
$198.9M
$-24.6M
Q3 25
$214.7M
$-27.9M
Q2 25
$216.0M
$-29.3M
Q1 25
$211.0M
$-52.4M
Q4 24
$210.1M
$-43.2M
Q3 24
$207.3M
$-77.0M
Q2 24
$205.3M
$-101.9M
Total Assets
MED
MED
PRCH
PRCH
Q1 26
$806.6M
Q4 25
$248.0M
$797.4M
Q3 25
$268.2M
$787.7M
Q2 25
$269.3M
$770.7M
Q1 25
$280.0M
$802.3M
Q4 24
$284.2M
$814.0M
Q3 24
$291.2M
$867.3M
Q2 24
$293.5M
$876.1M
Debt / Equity
MED
MED
PRCH
PRCH
Q1 26
14.87×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
PRCH
PRCH
Operating Cash FlowLast quarter
$-5.3M
Free Cash FlowOCF − Capex
$-6.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
PRCH
PRCH
Q1 26
Q4 25
$-5.3M
$1.2M
Q3 25
$12.1M
$40.8M
Q2 25
$-3.4M
$35.6M
Q1 25
$3.4M
$-11.2M
Q4 24
$-4.9M
$-26.6M
Q3 24
$9.1M
$12.4M
Q2 24
$13.1M
$-26.0M
Free Cash Flow
MED
MED
PRCH
PRCH
Q1 26
Q4 25
$-6.6M
$1.1M
Q3 25
$10.8M
$40.7M
Q2 25
$-4.8M
$35.4M
Q1 25
$1.9M
$-11.2M
Q4 24
$-7.2M
$-26.8M
Q3 24
$7.7M
$12.2M
Q2 24
$11.1M
$-26.0M
FCF Margin
MED
MED
PRCH
PRCH
Q1 26
Q4 25
-8.8%
1.0%
Q3 25
12.0%
35.4%
Q2 25
-4.5%
33.0%
Q1 25
1.6%
-13.3%
Q4 24
-6.1%
-35.6%
Q3 24
5.5%
15.7%
Q2 24
6.6%
-34.3%
Capex Intensity
MED
MED
PRCH
PRCH
Q1 26
Q4 25
1.8%
0.1%
Q3 25
1.5%
0.1%
Q2 25
1.3%
0.2%
Q1 25
1.3%
0.1%
Q4 24
1.9%
0.3%
Q3 24
1.0%
0.3%
Q2 24
1.1%
0.1%
Cash Conversion
MED
MED
PRCH
PRCH
Q1 26
Q4 25
Q3 25
Q2 25
-1.36×
13.79×
Q1 25
-1.33×
Q4 24
-0.87×
Q3 24
8.04×
0.86×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons